Affiliation:
1. Department of Pharmacology, Graduate School of Pharmaceutical Sciences Chiba Institute of Science 15‐8 Shiomi‐cho Choshi Chiba 288‐0025 Japan
2. Department of Hospital Pharmacy, Graduate School of Pharmaceutical Sciences Nagoya City University 3‐1 Tanabe‐dori, Mizuho‐ku Nagoya 467‐8603 Japan
3. Department of Clinical Pharmaceutics, Graduate School of Medical Sciences Nagoya City University 1‐Kawasumi, Mizuho‐cho, Mizuho‐ku Nagoya 467‐8601 Japan
Abstract
AbstractBackgroundErectile dysfunction (ED) is one of the causes of male infertility and is a disease that requires treatment. The first‐line drugs for ED are phosphodiesterase 5 (PDE‐5) inhibitors, and further treatment options are currently limited. Medical technologies, such as genetic control and regenerative medicine, are developing rapidly. Research on erectile function is progressing rapidly, coupled with technological innovations in other areas.MethodsA PubMed search using the keywords “animal (rat, mouse, rabbit, dog, and monkey)” and “erectile” was conducted, and all relevant peer‐reviewed English results were evaluated.Main findingsThe methods for evaluating erectile function include intracavernous pressure (ICP) measurements, isometric tension studies, and dynamic infusion cavernosometry. Papers also reported various disease model animals for the study of diabetes mellitus, cavernous nerve injury, and drug‐induced ED.ConclusionBasic research on ED treatment has progressed rapidly over the past 20 years. In particular, research on the mechanism of ED has been accelerated by the publication of a study on the evaluation of erectile function using ICP measurements in rats. In addition, molecular biological experimental methods such as polymerase chain reaction (PCR) and western blotting have become relatively easy to perform due to technological progress, thus advancing research development.
Subject
Cell Biology,Reproductive Medicine
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献